Sectors News Results

  • Germany's Chemical Industry Improved in 3Q But Difficulties Remain

    German chemical industry group VCI said Wednesday that industry conditions improved in the third quarter after setbacks caused by the coronavirus pandemic, but it still expects declines in the full year compared with 2019.. Industry sales and producer prices rose in the period, but all indicators remained significantly lower than in the previous year, VCI said. Sales were up 2.8% to 43.8 billion euros compared with the second quarter, with domestic sales alone up 3.5%.

  • Covid-19 Gives Boost to China's Telemedicine Industry -- Journal Report

    As the Covid-19 pandemic swept across China in late January, the country's telemedicine platforms raced to roll out free coronavirus-related services and the once wary government moved to ease regulations on providers, giving new life to a fledgling industry that has largely been losing money. The effort, involving some of China's largest technology companies, has introduced millions of people to online medicine in what industry analysts say could mark a watershed moment...

  • Pandemic Pets Push Industry Stocks to Pricey Valuations

    The pet business has been among the great beneficiaries of the new coronavirus. That success has made some stocks in the sector expensive. Among the sector's big winners this year are veterinary services firm Idexx Laboratories (IDXX), up about 61% this year, and drug company Zoetis Inc. (ZTS), which is 25% higher.

  • New York State Can Enact $200 Million Tax on Opioid Industry, Court Rules

    New York state won court permission to collect $200 million from the makers and distributors of opioid painkillers to help combat the costs of opioid addiction. The ruling Monday by a federal appellate court came in litigation brought by pharmaceutical industry groups to block a state law taxing all companies that sold or distributed opioids in the state. The challengers argued such a tax was unconstitutional and an end-run around lawsuits filed by New York against many of...

Search News

Filter Results

Publication Date

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.